150 related articles for article (PubMed ID: 28815651)
1. Peptide Mimetic Drugs for Modulating Thrombosis and Hemostasis.
Nellenbach K; Brown AC
Drug Dev Res; 2017 Sep; 78(6):236-244. PubMed ID: 28815651
[TBL] [Abstract][Full Text] [Related]
2. Blood coagulation: hemostasis and thrombin regulation.
Tanaka KA; Key NS; Levy JH
Anesth Analg; 2009 May; 108(5):1433-46. PubMed ID: 19372317
[TBL] [Abstract][Full Text] [Related]
3. [An antithrombotic therapy from the viewpoint of hematology].
Asakura H
Brain Nerve; 2015 Jan; 67(1):83-91. PubMed ID: 25585437
[TBL] [Abstract][Full Text] [Related]
4. Platelets and Their Role in Hemostasis and Thrombosis-From Physiology to Pathophysiology and Therapeutic Implications.
Scridon A
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361561
[TBL] [Abstract][Full Text] [Related]
5. Potential new targets for antithrombotic therapy.
Gruber A; Hanson SR
Curr Pharm Des; 2003; 9(28):2367-74. PubMed ID: 14529397
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
Jespersen J
Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
[TBL] [Abstract][Full Text] [Related]
7. Thrombosis and the pharmacology of antithrombotic agents.
Haines ST; Bussey HI
Ann Pharmacother; 1995 Sep; 29(9):892-905. PubMed ID: 8547739
[TBL] [Abstract][Full Text] [Related]
8. Drug-induced alterations of hemostasis and fibrinolysis.
Fareed J; Hoppenstedt D; Bick RL; Bacher P
Hematol Oncol Clin North Am; 1992 Dec; 6(6):1229-45. PubMed ID: 1452510
[TBL] [Abstract][Full Text] [Related]
9. Synergistic antithrombotic properties of G4120, a RGD-containing synthetic peptide, and argatroban, a synthetic thrombin inhibitor, in a hamster femoral vein platelet-rich thrombosis model.
Imura Y; Stassen JM; Vreys I; Lesaffre E; Gold HK; Collen D
Thromb Haemost; 1992 Sep; 68(3):336-40. PubMed ID: 1440501
[TBL] [Abstract][Full Text] [Related]
10. [Hemostasis and blood coagulation revisited: mechanisms and therapeutic implications].
Hermans C; Deneys V
J Pharm Belg; 2004; 59(1):15-26. PubMed ID: 15129576
[TBL] [Abstract][Full Text] [Related]
11. Haemostasis, anticoagulants and fibrinolysis.
Casey G
Nurs Stand; 2003 Oct 29-Nov 4; 18(7):45-51; quiz 53, 55. PubMed ID: 14639979
[TBL] [Abstract][Full Text] [Related]
12. Prediction of the therapeutic index of marketed anti-coagulants and anti-platelet agents by guinea pig models of thrombosis and hemostasis.
Bird JE; Giancarli MR; Allegretto N; Barbera F; Wong P; Schumacher WA; Ogletree ML; Seiffert D
Thromb Res; 2008; 123(1):146-58. PubMed ID: 18479740
[TBL] [Abstract][Full Text] [Related]
13. Hemostatic and hemorrhagic problems in neurosurgical patients.
Gerlach R; Krause M; Seifert V; Goerlinger K
Acta Neurochir (Wien); 2009 Aug; 151(8):873-900; discussion 900. PubMed ID: 19557305
[TBL] [Abstract][Full Text] [Related]
14. Antithrombotic therapy: new areas to understand efficacy and bleeding.
Wisler JW; Becker RC
Expert Opin Ther Targets; 2014 Dec; 18(12):1427-34. PubMed ID: 25347453
[TBL] [Abstract][Full Text] [Related]
15. Glybenclamide: an antidiabetic with in vivo antithrombotic activity.
Ting HJ; Khasawneh FT
Eur J Pharmacol; 2010 Dec; 649(1-3):249-54. PubMed ID: 20858477
[TBL] [Abstract][Full Text] [Related]
16. [Differential prevention of recurrence of thrombosis during pregnancy].
Makatsariia AD; Prosviriakova IG; Mishchenko AL; Kazakova LA
Akush Ginekol (Mosk); 1990 Jul; (7):31-5. PubMed ID: 2240446
[TBL] [Abstract][Full Text] [Related]
17. Foundation and sites of action of antithrombotic agents.
Marder VJ; Rosove MH; Minning DM
Best Pract Res Clin Haematol; 2004 Mar; 17(1):3-22. PubMed ID: 15171955
[TBL] [Abstract][Full Text] [Related]
18. Management of coagulation abnormalities in liver disease.
Potze W; Porte RJ; Lisman T
Expert Rev Gastroenterol Hepatol; 2015 Jan; 9(1):103-14. PubMed ID: 24970667
[TBL] [Abstract][Full Text] [Related]
19. Nontoxic polyphosphate inhibitors reduce thrombosis while sparing hemostasis.
Travers RJ; Shenoi RA; Kalathottukaren MT; Kizhakkedathu JN; Morrissey JH
Blood; 2014 Nov; 124(22):3183-90. PubMed ID: 25202141
[TBL] [Abstract][Full Text] [Related]
20. Platelet GPIb complex as a target for anti-thrombotic drug development.
Clemetson KJ; Clemetson JM
Thromb Haemost; 2008 Mar; 99(3):473-9. PubMed ID: 18327394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
